287 related articles for article (PubMed ID: 33714186)
1. Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy.
Gong Z; Liu X; Zhou B; Wang G; Guan X; Xu Y; Zhang J; Hong Z; Cao J; Sun X; Gao Z; Lu H; Pan X; Bai J
Colloids Surf B Biointerfaces; 2021 Jun; 202():111673. PubMed ID: 33714186
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
[TBL] [Abstract][Full Text] [Related]
3. Integrin-targeted zwitterionic polymeric nanoparticles with acid-induced disassembly property for enhanced drug accumulation and release in tumor.
Huang P; Song H; Wang W; Sun Y; Zhou J; Wang X; Liu J; Liu J; Kong D; Dong A
Biomacromolecules; 2014 Aug; 15(8):3128-38. PubMed ID: 25054812
[TBL] [Abstract][Full Text] [Related]
4. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.
Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z
Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464
[No Abstract] [Full Text] [Related]
5. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
6. A sequentially responsive and structure-transformable nanoparticle with a comprehensively improved 'CAPIR cascade' for enhanced antitumor effect.
Xu C; Sun Y; Yu Y; Hu M; Yang C; Zhang Z
Nanoscale; 2019 Jan; 11(3):1177-1194. PubMed ID: 30601512
[TBL] [Abstract][Full Text] [Related]
7. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
8. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
9. A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer.
Zhai L; Luo C; Gao H; Du S; Shi J; Wang F
Int J Nanomedicine; 2021; 16():3185-3199. PubMed ID: 34007173
[TBL] [Abstract][Full Text] [Related]
10. pH-triggered morphological change in a self-assembling amphiphilic peptide used as an antitumor drug carrier.
Gong Z; Liu X; Wu J; Li X; Tang Z; Deng Y; Sun X; Chen K; Gao Z; Bai J
Nanotechnology; 2020 Apr; 31(16):165601. PubMed ID: 31891937
[TBL] [Abstract][Full Text] [Related]
11. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
Haque ST; Islam RA; Gan SH; Chowdhury EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
[No Abstract] [Full Text] [Related]
12. Smart Nanoparticles Undergo Phase Transition for Enhanced Cellular Uptake and Subsequent Intracellular Drug Release in a Tumor Microenvironment.
Ye G; Jiang Y; Yang X; Hu H; Wang B; Sun L; Yang VC; Sun D; Gao W
ACS Appl Mater Interfaces; 2018 Jan; 10(1):278-289. PubMed ID: 29260563
[TBL] [Abstract][Full Text] [Related]
13. Small Peptide-Doxorubicin Co-Assembly for Synergistic Cancer Therapy.
Li S; Chen X; Chen H; Peng J; Yang X
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979298
[TBL] [Abstract][Full Text] [Related]
14. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
[TBL] [Abstract][Full Text] [Related]
15. Multi-stimuli responsive hollow MnO
Xu X; Duan J; Liu Y; Kuang Y; Duan J; Liao T; Xu Z; Jiang B; Li C
Acta Biomater; 2021 May; 126():445-462. PubMed ID: 33785453
[TBL] [Abstract][Full Text] [Related]
16. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
17. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug.
Jiang X; Fan X; Xu W; Zhao C; Wu H; Zhang R; Wu G
J Control Release; 2019 Dec; 316():196-207. PubMed ID: 31682910
[TBL] [Abstract][Full Text] [Related]
19. Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release.
Li Y; Lin J; Zhi X; Li P; Jiang X; Yuan J
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():606-614. PubMed ID: 30033293
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-triggered self-assembly of native amphiphilic peptides into spherical nanoparticles.
Fan X; Zhao F; Wang X; Wu G
Oncotarget; 2016 Sep; 7(36):58445-58458. PubMed ID: 27533248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
